|
|
News Breaks
|
October 28, 2009
|
| 07:19 EDT |  | INCY |
| theflyonthewall.com: | Incyte upgraded to Outperform from Neutral at Cowen | | Cowen has increased confidence in Incyte's lead drug candidate, '424, in myelofibrosis and views valuation as attractive. :theflyonthewall.com |
|
|
News For INCY From The Last 14 Days Check below for free stories on INCY the last two weeks.
| Sign up for a free trial to see the rest of the stories you've been missing. |
There are no results for these search parameters.
|
|
|
|
